Anticancer effects of methanol extract of Myrmecodia platytyrea Becc. leaves against human hepatocellular carcinoma cells via inhibition of ERK and STAT3 signaling pathways

International Journal of Oncology
Anna JuSayeon Cho

Abstract

Myrmecodia platytyrea Becc., a member of the Rubiaceae family, is found throughout Southeast Asia and has been traditionally used to treat cancer. However, there is limited pharmacological information on this plant. We investigated the anticancer effects of the methanol extract of Myrmecodia platytyrea Becc. leaves (MMPL) and determined the molecular mechanisms underlying the effects of MMPL on metastasis in human hepatocellular carcinoma (HCC) cells. MMPL dose-dependently inhibited cell migration and invasion in SK‑Hep1 and Huh7 cells. In addition, MMPL strongly suppressed the enzymatic activity of matrix metalloproteinases (MMP‑2 and MMP‑9). Diminished telomerase activity by MMPL resulted in the suppression of both telomerase activity and telomerase-associated gene expression. The levels of urokinase-type plasminogen activator receptor (uPAR) expression as well as the phosphorylation levels of signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinase (ERK) were also attenuated by MMPL. The above results collectively suggest that MMPL has anticancer effects in HCC and that MMPL can serve as an effective therapeutic agent for treating human liver cancer.

References

Aug 1, 1976·Environmental Health Perspectives·I Y Adamson
Jan 1, 1996·Developmental Genetics·W E WrightJ W Shay
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J W Shay, S Bacchetti
Apr 6, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K DanøL R Lund
Oct 12, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S M Ellerbroek, M S Stack
Jan 22, 2002·International Journal of Cancer. Journal International Du Cancer·Gianluigi GiannelliSalvatore Antonaci
Feb 21, 2002·The Journal of Biological Chemistry·Emanuelle PascoloAndreas Schnapp
Mar 27, 2003·Bioorganic & Medicinal Chemistry Letters·D K BarmaDavid R Corey
Apr 12, 2003·The Journal of Biological Chemistry·Gregory HelbigHarikrishna Nakshatri
May 2, 2003·Nature Reviews. Cancer·Peter Friedl, Katarina Wolf
Mar 17, 2004·Cancer Treatment Reviews·Juan Angel Fresno VaraManuel González-Barón
Mar 12, 2005·World Journal of Gastroenterology : WJG·Elzbieta SkrzydlewskaStanislaw Sulkowski
Aug 8, 2006·Nature Medicine·Patricia S Steeg
Jul 31, 2007·Cell·Manuel ColladoManuel Serrano
Dec 13, 2007·Nucleic Acids Research·Joshua D PodlevskyJulian J-L Chen
Jan 31, 2008·British Journal of Cancer·J W Shay, W N Keith
Feb 7, 2008·Nature Clinical Practice. Oncology·Patricia S Steeg, Dan Theodorescu
May 8, 2008·Bioscience, Biotechnology, and Biochemistry·Toshio NorikuraIsao Matsui-Yuasa
Sep 11, 2008·Current Drug Metabolism·Avni G DesaiHari K Bhat
Feb 10, 2009·Current Cancer Drug Targets·Salvatore UlisseMassimino D'Armiento
Aug 12, 2009·Anti-cancer Agents in Medicinal Chemistry·Kiyotaka KawauchiOsamu Yamada
Dec 2, 2009·Methods in Molecular Biology·Xing-Jie LiangPaul C Wang
Dec 23, 2009·Nature Reviews. Molecular Cell Biology·Harvey W Smith, Chris J Marshall
Jan 13, 2010·Cold Spring Harbor Perspectives in Biology·Andrea Oeckinghaus, Sankar Ghosh
Mar 17, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N R Srinivas
May 5, 2010·Pakistan Journal of Biological Sciences : PJBS·A SoeksmantoP Simanjuntak
Oct 16, 2010·Journal of Proteome Research·Rukhsana SultanaD Allan Butterfield
Mar 8, 2011·Microbial Biotechnology·Arnold L Demain, Preeti Vaishnav
Jun 22, 2011·Clinics in Liver Disease·Katherine A McGlynn, W Thomas London
Jul 22, 2011·Journal of Signal Transduction·Banibrata Sen, Faye M Johnson
Jul 23, 2011·Chinese Medicine·Wen TanYitao Wang
Aug 23, 2011·Recent Patents on Anti-cancer Drug Discovery·Apurva AgrawalReema Gabrani
Jul 7, 2012·PloS One·Jin-Jian LuYi-Tao Wang
Dec 15, 2012·Critical Reviews in Oncogenesis·Thomas N Seyfried, Leanne C Huysentruyt
Apr 6, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hanna HolyszBlazej Rubis
Apr 10, 2013·Asian Pacific Journal of Tropical Biomedicine·Sasipawan MachanaWaraporn Tanthanuch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.